Hajjar I, Kotchen T A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States(1988—2000)[J]. J Amer Med Assoc,2003, 290:199.
[2]
Wang J, Xiong X J. Current situation and perspectives of clinical study in integrative medicine in China[J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/268542.
[3]
Lloyd-Jones D M,Hong Y,Labarthe D,et al. Defining and setting national goals for cardiovascular health promotion and disease reduction:the American heart association\'s strategic impact goal through 2020 and beyond[J]. Circulation,2010,121:586.
[4]
Wang J, Xiong X J. Control strategy on hypertension in Chinese medicine[J]. Evid-Based Compl Alt Med, 2012, doi:10. 1155/2012/284847.
[5]
董吁钢,陈广琴.不应忽视高血压前期的防治[J].岭南心血管病杂志,2008,14(2):77.
[6]
Xu H, Chen K J. Complementary and alternative medicine:is it possible to be main stream?[J]. Chin J Integr Med, 2012, 18(6):403.
[7]
Wang J, Xiong X J. Outcome measures of Chinese herbal medicine for hypertension:an overview of systematic reviews[J]. Evid-Based Compl Alt Med, 2012, doi:10. 1155/2012/697237.
[8]
Xiong X J, Chu F Y, Li H X, et al. Clinical application of the TCM classic formulae for treating chronic bronchitis[J]. J Tradit Chin Med, 2011, 31 (1):69.
[9]
Xu H, Chen K J. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system[J]. Chin J Integr Med, 2011, 17(2):83.
Manciag, Debackerg, Dominiczaka, et al. 2007 guidelines for the management of arterial hypertension:the task force for the management of arterial hypertension of the European society of hypertension(ESH)and of the European society of cardiology(ESC)[J]. J Hypertens, 2007, 25(6):1105.
Manios E, Tsivgoulis G, Koroboki E, et al. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass[J]. Stroke, 2009, 40(4):1515.
[17]
Drukteinis J S, Roman M J, Fabsitz R R, et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults:the strong heart study[J]. Circulation, 2007, 115(2):221.
[18]
Toprak A, Wang H, Chen W, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults:Bogalusa heart study[J]. J Hypentens, 2009,27(2):243.
[19]
Ikram M K,Witteman J C,Vingerling J R,et al. Retinal vessel diameters and risk of hypertension:the Rotterdam study[J]. Hypertension,2006,19(2):189.
[20]
Manios E,Tsivgoulis G,Koroboki E,et al. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass[J]. Stroke,2009,40(4):1515.
[21]
Weil B R,Stauffer B L,Greiner J J,et al. Prehypertension is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation in sedentary adults[J]. Am J Hypertens,2011,24(9):976.
[22]
Markus M R,Stritzke J,Lieb W,et al. Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function:the MONICA/KORA augsburg study[J]. J Hypertens,2008,26(10):2040.
[23]
Qureshi A I,Suri M F,Kirmani J F,et al. Is prehypertension a risk factor for cardiovascular diseases[J]. Stroke,2005,36(9):1859.
[24]
Holmes E,Loo R L,Stamler J,et al. Human metabolic phenotype diversity and its association with diet and blood pressure[J]. Nature,2008,453(7193):396.
Shirmila S, Li J L, Anoop S, et al, Association between serum uric acid and prehypertension among US adults[J]. J Hypertension,2007,25:1583.
[29]
Maneia G, De BackerG, Dominiezak A, et al. ESH-ESC task force on the management of arterial hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension:ESH-ESC task force on the management of arterial hypertension [J]. J Hypertens, 2007, 25:1751.
[30]
Weintraub W S,Daniels S R,Burke L E,et al. Value of primordial and primary prevention for cardiovascular disease:a policy statement from the American Heart Association[J]. Circulation,2011,124(8):967.
[31]
Elmer P J,Stevens V J,Vollmer W M,et al. Effects of comprehensive lifestyle modification on blood pressure control:main results of the PREMIER clinical trial[J]. J Amer Med Assoc,2003,289(16):2083.
[32]
Sacks F M, Svetkey L P, Vollmer W M, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet[J]. N Engl J Med, 2001, 344:3210.
[33]
Julius S,Nesbitt S D,Egan B M,et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker[J].N Engl J Med,2006,354(16):1685.
[34]
Luders S,Schrader J,Berger J,et al. The PHARAO study:prevention of hypertension with the angiotension converting enzyme inhibitor ramipril in patients with high-normal blood pressure a prospective,randomized,controlled prevention trial of the German Hypertension League[J]. J Hypertens,2008,26(7):1487.
[35]
Fuchs F D,Fuchs S C,Moreira L B,et al. Prevention of hypertension in patients with pre-hypertension:protocol for the PREVER-prevention trial[J].Trials,2011,12:65.
Wang J, Wang P Q, Xiong X J. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine[J]. Internal Med, 2012, doi:10. 4172/2165-8048. 1000113.
Wang J, Yao K W, Yang X C, et al. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension:a systematic review of randomized controlled trials[J]. Evid-Based Compl Alt Med, 2012, doi:10. 1155/2012/714805.
[48]
Xiong X J, Yang X C, Liu W, et al. Banxia baizhu tianma decoction for essential hypertension:a systematic review of randomized controlled trials[J]. Evid-Based Compl Alt Med, 2012, doi:10. 1155/2012/271462.
